Cargando…
Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway
Bushenkangshuai tablet (BSKS) is a Chinese herbal compound which has been used for the treatment of cardiovascular and cerebrovascular diseases in China for decades. This study intends to explore the molecular mechanism of BSKS against atherosclerosis in ApoE(−/−) mice. ApoE(−/−) mice were fed with...
Autores principales: | Pang, Shu-chao, Peng, Li, Zhang, Jun-ping, Wang, Yuan-yuan, Jia, Hui-yun, Bi, Li-yuan, Chen, Mei-ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829360/ https://www.ncbi.nlm.nih.gov/pubmed/29619063 http://dx.doi.org/10.1155/2018/1758383 |
Ejemplares similares
-
BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice
por: Pang, Shu-chao, et al.
Publicado: (2019) -
Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
por: Zhu, Liping, et al.
Publicado: (2018) -
Chondroprotective and anti‐inflammatory effects of amurensin H by regulating TLR4/Syk/NF‐κB signals
por: Ma, Pei, et al.
Publicado: (2019) -
Gastrodin improves preeclampsia‐induced cell apoptosis by regulation of TLR4/NF‐κB in rats
por: Mei, Zhixiong, et al.
Publicado: (2020) -
Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions
por: Malgor, Ramiro, et al.
Publicado: (2013)